Clinical Trial Update: Androgen for Leydig Cell Proliferation [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating an androgen therapy for Leydig cell proliferation disorders in men with Klinefelter syndrome and hypergonadotropic hypogon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypergonadotropic Azospermia
• Hypergonadotropic Cryptozoospermia
• Hypergonadotropic Hypogonadism
• Klinefelter Syndrome

Drugs mentioned

• Androgen therapy (androgen)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Klinefelter Syndrome, Hypergonadotropic Hypogonadism | Phase 2, Phase 3 | Status: COMPLETED